Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma
American Journal of Clinical and Experimental Immunology · 2026 · 15 (5) · 383-397
DOI: 10.62347/jvmv3248 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Wanyu Dong und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dong, W., Wei, R., Deng, R., Lu, D., & Zhang, Y. (2026). Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma. American Journal of Clinical and Experimental Immunology, 15(5), 383-397. https://doi.org/10.62347/jvmv3248
Vancouver
Dong W, Wei R, Deng R, Lu D, Zhang Y. Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma. American Journal of Clinical and Experimental Immunology. 2026;15(5):383-397. doi:10.62347/jvmv3248
BibTeX
@article{Dong2026,
author = {Dong, Wanyu and Wei, Rong and Deng, Rushuang and Lu, Daru and Zhang, Yanqiu},
title = {Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2026},
volume = {15},
number = {5},
pages = {383--397},
doi = {10.62347/jvmv3248}
}
EUVIMED